cm313
Small moleculeexperimental
Clinical trial activity
13 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
10
Phase 3
0
Phase 4
0
Earliest trial started Apr 26, 2021 (NCT04818372)
Timeline
Indications
Studied for
- Anemia, Aplastic · Phase 1/Phase 2
- Blood Transfusion · Phase 1/Phase 2
- Glomerulonephritis, IGA · Phase 2
- Healthy Volunteers · Phase 1
- Lupus Erythematosus, Systemic · Phase 2
- Lymphoma · Phase 1
- Multiple Myeloma · Phase 1/Phase 2
- Pemphigus · Phase 1/Phase 2
- Purpura, Thrombocytopenic, Idiopathic · Phase 2
- Therapeutics · Phase 2
- Thrombocytopenia · Phase 2
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06663943 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2025 | Fujian Medical University |
| NCT06904040 | N/A | Apr 1, 2025 | Sichuan University |
| NCT06791824 | Phase 1/Phase 2 (Phase 2) | Mar 31, 2025 | China Academy of Chinese Medical Sciences, Keymed Biosciences Co.Ltd |
| NCT06830395 | Phase 2 | Mar 31, 2025 | Keymed Biosciences Co.Ltd |
| NCT06792019 | Phase 1/Phase 2 (Phase 2) | Mar 25, 2025 | China Academy of Chinese Medical Sciences, Keymed Biosciences Co.Ltd |
| NCT06791772 | Phase 2 | Feb 28, 2025 | Chinese Academy of Medical Sciences, Keymed Biosciences Co.Ltd |
| NCT06594146 | Phase 2 | Dec 30, 2024 | Chinese Academy of Medical Sciences, Keymed Biosciences Co.Ltd |
| NCT06285227 | Phase 1 | Mar 12, 2024 | Fudan University, Keymed Biosciences Co.Ltd |
| NCT06126237 | Phase 1/Phase 2 (Phase 2) | Feb 28, 2024 | Keymed Biosciences Co.Ltd |
| NCT06199089 | Phase 2 | Jan 16, 2024 | China Academy of Chinese Medical Sciences, Henan Medical University, Kunming Medical University, North China University of Science and Technology Affiliated Hospital, Tianjin Medical University |
| NCT05694767 | Phase 2 | Jan 22, 2023 | China Academy of Chinese Medical Sciences |
| NCT05465707 | Phase 1/Phase 2 (Phase 2) | Oct 30, 2022 | Keymed Biosciences Co.Ltd |
| NCT04818372 | Phase 1 | Apr 26, 2021 | Capital Medical University, Keymed Biosciences Co.Ltd |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Keymed Biosciences Co.Ltd | For profit | 9 | 9 | 2 | 2021 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 4 | 2 | 1 | 2023 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 0 | 1 | 2024 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Fujian Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Kunming Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| North China University of Science and Technology Affiliated Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Sichuan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Tianjin Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
11 organizations
Page 1 / 1